A new research claims that, the drug companies have faced a new problem of low libido in the body of women so that they can sell newly invented drugs.
Meanwhile the medicine industry is accused of making the label of female sex dysfunction in to cash by various medicines. According to the researcher Ray Moynihan the employees of the drug companies are paying the doctors to talk about the sexual disorders and treatments.
While the researcher has argued that the trails of the drugs related to the lower level of libido have failed so far as no impotents have been seen in the health conditions of the patients using those drugs.
The definition of the female sexual dysfunction (FSD) has been criticized by most of the health experts.
Experts say this issue is a mixture of health science and marketing as the drug marketing is emerging as a major factor in the drug industry. The drug makers have not sponsored the science of the new market condition.
Most of the involved people in the market have pointed out the financial ties as the main reason behind it.